Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

NCT07176182 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

236

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer Patients
Rectal Cancer Stage II
Rectal Cancer Stage III

Interventions

DRUG: mFOLFOX regimen combined with Citrus Flavone Tablets (Alvenor) neoadjuvant treatment group
DRUG: mFOLFOX regimen neoadjuvant therapy group

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]